If you want to know about generic pharmaceuticals - please contact us to see how we can help
35 years’ experience of the European pharmaceutical industry in general and 30 years in generics in particular gives Interpharm the background to help you with whatever issues you may be facing.
Whether you are thinking about:
please contact us. We can also help with in-house training that is tailored to your company’s individual needs on topics such as understanding the generic market and the legal and IP issues that affect it. To find out more about training and symposia and previous speaking engagements at conferences, please follow the link.
Interpharm and MK Consulting will be jointly running a full-day seminar on Thursday 12th December in Istanbul on the topic
IP and the GENERIC INDUSTRY
About the Seminar
Intellectual Property plays an extremely significant role in the generic world. Professionals who want to make progress in the generic worldneeds to ensure that they have a good understanding of the basic issues, which this 1-day seminar is designed to provide.
The legal and regulatory environment in which EU generic companies operate is very complicated and highly regulated. As a result, it is often difficult for those involved in marketing generic medicines who work outside Europe to understand it. In the same way, it is often not clear to those working on the regulatory side how the legal and Intellectual Property framework can have an impact on their own work.
The workshop will examine all these issues and take a look into what the future may bring
Interpharm has been co-operating with various other conference organisers during during 2012 and 2013 to run a series of workshops in London on the topic of biosimilars and most recently ran one for SMi in London.
The Interpharm Biosimilars Workshop is also available as a half-day in-house seminar. Please click on the link to download the programme
Please click here to obtain an overview of the other services that Interpharm can offer including very competitively priced bioequivalence studies through a partnership with Cliantha Research in India.
What we do
Interpharm Consultancy has been serving the generic pharmaceutical industry since 1997. With a background of over 20 years in generics, we specialise in:-
Examples of previous projects
Interpharm has worked with a number of companies on a variety of generic related projects. Here are a few examples of these assignments:
Generic companies (generally for non-EU clients)
Some clients have asked for more than one of these services them and some activities have been carried out for several clients
To learn more about a recent report on Biosimilars and Biobetters please click on the link to Biobetters: Major Players and Market Prospects published by FirstWord for further information or see the News page. The report looks at the biobetters market and how interest has mounted in what is still a very young market. The report reviews the role Biosimilars have played, presents the rationale behind biobetters and how interest is is stirring in their development. In addition, the report concisely outlines how companies are evolving biobetters, the areas of greatest potential and reviews the ‘Achilles Heel’ of immunogenicity.
If you are interested to read a recent article about the generic industry that appeared in the GenericsWeb INNsight newsletter, please follow the link. For news about future speaking engagements please go to the News page.
At this site, you can learn more about Interpharm’s services, as well as how we can help your company to find its way into the UK or other European generic markets.
Interpharm is a London based consultancy managed by Peter Wittner that specialises in the area of generics and that offers advice on issues such as product sourcing, patent expiries, international marketing, bioavailability and bioequivalence studies. With over 30 years’ experience in pharmaceuticals of which 15 have been specifically in the generic field, Interpharm is the partner you need for exploring European generic markets in general and the UK in particular.
Apart from that, I am the author of several reports on the European and US generics industries for publishers such as Decision Resources, Arrowhead Publishing, Business Insights and Informa Pharmaceuticals /URCH Publishing and have spoken at generics symposia. There is more information about this in the Conferences section on the “About Interpharm” page
You are welcome to browse around this site. If you have comments or questions about my products or services, or simply need more information and want to contact me click on the contact button on any page within this site.
Thank you for visiting and I look forward to helping you.